Absence of p21 expression is associated with abnormal p53 in human breast carcinomas
Open Access
- 1 August 1997
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 76 (4) , 480-485
- https://doi.org/10.1038/bjc.1997.413
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patientsNature Medicine, 1996
- Alterations of the TP53 Gene as a Potential Prognostic Marker in Breast CarcinomasDiagnostic Molecular Pathology, 1995
- TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domainsGenes, Chromosomes and Cancer, 1995
- Evidence for a p53‐independent pathway for upregulation of SDI1/CIP1/WAF1/P21 RNA in human cellsMolecular Carcinogenesis, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- The p53-mdm-2 autoregulatory feedback loop.Genes & Development, 1993
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast CancerJNCI Journal of the National Cancer Institute, 1993
- The p53 tumour suppressor geneNature, 1991
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981